<div class="headers"><div>Figure 2. Glycated haemoglobin (HbA1c) change from baseline to 26 weeks by individual study. Data presented as LS means and 95% CIs. AWARD, Assessment of Weekly AdministRation of LY2189265 (dulaglutide) in Diabetes; BL, baseline; HbAlc, glycated haemoglobin; MET, metformin; SU, sulphonylurea; TZD, thiazolidinedione; yrs, years.</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey;'> </th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>row/col</th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>1(A)</th>
</tr>
</thead>
<tbody>
<tr>
<td style='text-align: left;'>1</td>
<td style='text-align: left;'>1</td>
<td style='text-align: left;'><p style="" class="">Figure 2. Glycated haemoglobin (HbA1c) change from baseline to 26 weeks by individual study. </p></td>
</tr>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'>2</td>
<td style='border-bottom: 2px solid grey; text-align: left;'>2</td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">Data presented as LS means and 95% CIs. AWARD, Assessment of Weekly AdministRation of LY2189265 (dulaglutide) in Diabetes; BL, baseline; HbAlc, glycated haemoglobin; MET, metformin; SU, sulphonylurea; TZD, thiazolidinedione; yrs, years.</p></td>
</tr>
</tbody>
</table>
